A detailed history of First Horizon Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 657 shares of TMDX stock, worth $57,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
657
Previous 663 0.9%
Holding current value
$57,231
Previous $99,000 4.04%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$135.68 - $176.11 $814 - $1,056
-6 Reduced 0.9%
657 $103,000
Q2 2024

Jul 19, 2024

BUY
$72.62 - $150.62 $4,284 - $8,886
59 Added 9.77%
663 $99,000
Q1 2024

Apr 26, 2024

SELL
$70.86 - $89.93 $31,532 - $40,018
-445 Reduced 42.42%
604 $44,000
Q4 2023

Feb 06, 2024

BUY
$36.74 - $81.08 $8,156 - $17,999
222 Added 26.84%
1,049 $82,000
Q3 2023

Oct 27, 2023

SELL
$53.47 - $96.07 $10,961 - $19,694
-205 Reduced 19.86%
827 $45,000
Q2 2023

Aug 03, 2023

BUY
$66.23 - $88.73 $32,320 - $43,300
488 Added 89.71%
1,032 $86,000
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $9,063 - $13,913
169 Added 45.07%
544 $41,000
Q4 2022

Feb 10, 2023

BUY
$39.08 - $64.29 $8,480 - $13,950
217 Added 137.34%
375 $23,000
Q3 2022

Nov 09, 2022

BUY
$31.56 - $55.75 $3,156 - $5,575
100 Added 172.41%
158 $6,000
Q2 2022

Aug 02, 2022

BUY
$20.56 - $32.15 $1,192 - $1,864
58 New
58 $1,000
Q1 2022

May 10, 2022

SELL
$12.58 - $26.94 $968 - $2,074
-77 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$19.16 - $32.68 $1,092 - $1,862
57 Added 285.0%
77 $1,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $233 - $310
-9 Reduced 31.03%
20 $0
Q3 2021

Nov 09, 2021

BUY
$25.92 - $34.51 $751 - $1,000
29 New
29 $0

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.77B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.